› Forums › General Melanoma Community › Melanoma Trial ends early due to great results
- This topic has 2 replies, 3 voices, and was last updated 3 years ago by Christinad.
- Post
-
- December 1, 2021 at 11:45 am
Viewing 0 reply threads
- Replies
-
-
- December 1, 2021 at 4:07 pm
You can add this data to the recent findings from Secombit trial which looked at Enco+ Bini targeted drugs vs Ipi+nivo with similar trial design. https://ascopost.com/issues/november-10-2021/secombit-trial-evaluates-optimal-treatment-sequencing-in-braf-mutated-melanoma/?utm_source=TAP-eTOC-111021-INTL&utm_medium=email&utm_term=39fe83317f5eb4d59820e06e559741f2#.YYxTTZSNvIY.twitter-
- December 1, 2021 at 10:23 pm
Thank you both for sharing! My interpretation of both articles is combination ipi/nivo is still most effective based on the results. Is that your understanding as well? Just want to make sure I’m still on the right track with my current treatment.
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.